The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
KA

k.adeyemi

TL2 Moderator · Monterrey

Contributes reviews on supplier material. Based in Monterrey.

Joined 5 August 2025 · last posted 11h

3 replies marked as the accepted answer.

  • SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #5 · marked as the solution · Compounds › Tirzepatide · 5 Sep 2025 · 7 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
  • A well-designed study with a badly written abstract — does this still hold? Replied, post #3 · marked as the solution · Evidence › Study critique · 16 Nov 2024 · 7 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
  • Pricing far outside the range, in either direction Replied, post #6 · marked as the solution · Sourcing › Red flags · 10 Nov 2025 · 9 likes On post #2 — agreed on the reasoning, with one qualification. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and…